AI assistant
Zealand Pharma Director's Dealing 2021
3391_rpt_2021-03-22_3deedb13-5037-4a00-9d60-ed5d76be148f.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1. | Details of the person discharging managerial responsibilities/person closely associated | |||
|---|---|---|---|---|
| a) | Name | Adam Steensberg | ||
| 2. | Reason for the notification | |||
| a) | Position/status | EVP, Chief Medical and Development Officer in Zealand Pharma A/S | ||
| b) | Initial notification/Amendment |
Initial notification | ||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||
| a) | Name | Zealand Pharma A/S, CVR-no. 20045078 |
||
| b) | LEI1 | 549300ITBB1ULBL4CZ12 | ||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||
| a) | Description of the financial instrument, type of instrument |
Warrants | ||
| Identification code | DK0060257814 | |||
| b) | Nature of the transaction | Exercise of warrants | ||
| c) | Price(s) and volume(s) | Price(s) | Volume(s) | |
| DKK 142,45 | 20.000 | |||
| d) | Aggregated information - Aggregated volume - Price |
DKK 2.849.000 | ||
| e) | Date of the transaction | 18 March 2021 |
||
| f) | Place of the transaction | Outside market place |